Nucleara LtdCambridge-based biotechnology company Nuclera has appointed William J. Kullback to its board of directors as a non-executive director.
Single Use SupportKufstein-based Single Use Support appointed Darren Verlenden as CEO and strengthens leadership team.
BiosynthMatt Gunnison was appointed as the new CEO of Biosynth, headquartered in Staad (CH). He started in November.
DiogenX SAThe French biotech company DiogenX is further strengthening its management team. In November, Dr Klara Owen was appointed as Chief Medical Officer.
Innate PharmaFrench Innate Pharma SA announced the appointment of Jonathan Dickinson as the Company’s newChief Executive Officer (CEO) and Chairman of the Executive Board. He succeeds Hervé Brailly, co-founder of the Company, who was interim CEO, during the search process.
AAX BiotechSwedish biotech company AAX Biotech AB has welcomed Patrik Strömberg as a new member of the Board of Directors.
Jean-Marie Huron for DiogenXThe biotech company DiogenX, based in Marseille (F), has appointed Hélène Sicard, PhD, as Chief Development Officer.
AstoriomLori A. Ball has been appointed as the new Chief Executive Officer of UK-based Astoriom. She will be responsible for driving the development of Astoriom’s sample management business in the US, UK and Europe.
Mogrify LtdCambridge-based Mogrify Ltd announces the appointment of Dr. Jonathan Appleby as Chief Scientific Officer.
A new Chief Business Officer strengthens the management team of Macomics Ltd (UK). Simon Drew took over the newly created position in June.